Physician profile
Hwal Lee
NPI 1255803359
$385.79
in general payments reported to CMS, 2019-2025
13 companies · $85.68 in 2025
The $85.68 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $300 · 2025: $85.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $74.88 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.72 | 2024 | Caplyta |
| Lilly USA, LLC | $38.84 | 2024-2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $35.87 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Lundbeck LLC | $33.24 | 2024-2025 | Rexulti |
| Ironshore Pharmaceuticals INC. | $28.80 | 2024 | |
| Bausch Health US, LLC | $24.75 | 2024 | Aplenzin |
| Alkermes, INC. | $19.96 | 2024 | Lybalvi |
| Exact Sciences Corporation | $17.96 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $17.50 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $16.01 | 2024 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $15.40 | 2024 | Zoryve |
| Corium, LLC | $9.86 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hwal Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.